Cannabics Pharmaceuticals

99 articles with Cannabics Pharmaceuticals

• Cannabics Pharmaceuticals Received a New Research License for Characterization of Anti-Tumor Activity of Cannabinoids

  11/28/2017

  The new license will enable the company to continue our vision of developing an ecosystem for creation of diagnostic tools and bringing to the market diagnostic services for cancer patients who are medicated with cannabis.

• Cannabics Pharma Files Patent Application on Cannabinoid Modulation of the Microbiome

  11/8/2017

  Cannabics Pharma announced today that it has filed the first of a cluster of patent applications with the USPTO which covers their ongoing work on the use of cannabinoid products for adjusting the varied microbial populations that live on and in the body.

• Cannabics Pharma Files National Phase Applications For Its System And Method For High Throughput Screening Of Cancer Cells

  9/25/2017

• Cannabics Pharma Files A Patent Application For Sensitivity Tests Of Cannabinoids On Patient Derived Tumor Biopsies And CTCs

  9/6/2017

• Cannabics Pharma Received Positive Report From The Patent Cooperation Treaty Regarding Cannabinoid Personalized Screening Of Cancer Cells

  8/29/2017

• Cannabics Pharma Establishes A Human-Cannabis-Cancer Genetics Lab To Expand Its Personalized Diagnostics

  7/24/2017

• Cannabics Pharma Executed A Final Collaboration Agreement With SIMFO GmbH

  7/12/2017

• Cannabics Pharma Provides Shareholders Update June 2107

  6/2/2017

• Cannabics Pharma Raises $3,000,000 In Capital Raise Transaction

  5/10/2017

• Cannabics Pharma Announces Scientific Collaboration With A Leading CTC European Lab

  5/4/2017

• Cannabics Pharma Receives The Final Report Of Its Research On Antitumor Properties Of Cannabinoids Held In Israel

  4/4/2017

• Cannabics Pharma Receives The Final Report Of Its Research On Antitumor Properties Of Cannabinoids Held In Israel

  4/3/2017

• Cannabics Pharma Appoints New Members To Its Board Of Advisors

  3/10/2017

• Cannabics Pharma Provides Shareholders Update Regarding Increased Volume In Its Shares

  2/23/2017

• Cannabics Pharma Announces Initial Commercialization Of Cannabinoids-Based Personalized Diagnostics For Cancer Patients

  2/7/2017

• Cannabics Pharma Announces A New Dosage Of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering From Cachexia And Anorexia Syndrome

  1/3/2017

• Cannabics Pharma Announces Specific Ratios Of Cannabinoids Led To Apoptosis In MDA-MB-231 Breast Cancer Cell Viability

  12/1/2016

• Cannabics Pharma Discovers Specific Ratios Of THC/CBD Effectuate Reduction In U87MG Glioblastoma Cell Viability

  10/24/2016

• Cannabics Pharma Discovers Specific Ratios Of THC/CBD Effectuate Reduction In U87MG Glioblastoma Cell Viability

  10/20/2016